Company review

Admedus Revisited

Financial Results for 2015 I have followed this fledgling biotech company since February 2013, when the shares were trading at 2.2 cents a share following a 2 cent capital raising. Two and a half years later, after another three capital… Read More ›

CBA Chart review

CBA has been in a strong uptrend since October last year. A record high of $96.60 was reached on the 23/3/2015 prior to the share-price entering into a triangular trading range, with the prices easing somewhat. In the last two… Read More ›